Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Renee Menezes

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Radiology. Cardiothoracic Imaging|May 1, 2023
Artificial Intelligence Tool for Detection and Worklist Prioritization Reduces Time to Diagnosis of Incidental Pulmonary Embolism at CTLaurens Topff, Erik R Ranschaert, Annemarieke Bartels-Rutten, et al.
European Radiology|March 11, 2024
Artificial intelligence-assisted double reading of chest radiographs to detect clinically relevant missed findings: a two-centre evaluationLaurens Topff, Sanne Steltenpool, Erik R Ranschaert, et al.
Research Square|January 3, 2024
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancerMarcelo Sobral-Leite, Simon Castillo, Shiva Vonk, et al.
Biosensors|May 15, 2020
Fecal Volatile Organic Compound Profiles are Not Influenced by Gestational Age and Mode of Delivery: A Longitudinal Multicenter Cohort StudyNancy Deianova, Sofia El Manouni El Hassani, Hendrik J Niemarkt, et al.
NPJ Precision Oncology|January 28, 2025
A morphometric signature to identify ductal carcinoma in situ with a low risk of progressionMarcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
Nature|December 5, 2024
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapyLaura Bornes, Lennart J van Winden, Veerle C M Geurts, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Radiology. Cardiothoracic Imaging|May 1, 2023
Artificial Intelligence Tool for Detection and Worklist Prioritization Reduces Time to Diagnosis of Incidental Pulmonary Embolism at CTLaurens Topff, Erik R Ranschaert, Annemarieke Bartels-Rutten, et al.
European Radiology|March 11, 2024
Artificial intelligence-assisted double reading of chest radiographs to detect clinically relevant missed findings: a two-centre evaluationLaurens Topff, Sanne Steltenpool, Erik R Ranschaert, et al.
Research Square|January 3, 2024
Artificial intelligence-based morphometric signature to identify ductal carcinoma in situ with low risk of progression to invasive breast cancerMarcelo Sobral-Leite, Simon Castillo, Shiva Vonk, et al.
Biosensors|May 15, 2020
Fecal Volatile Organic Compound Profiles are Not Influenced by Gestational Age and Mode of Delivery: A Longitudinal Multicenter Cohort StudyNancy Deianova, Sofia El Manouni El Hassani, Hendrik J Niemarkt, et al.
NPJ Precision Oncology|January 28, 2025
A morphometric signature to identify ductal carcinoma in situ with a low risk of progressionMarcelo Sobral-Leite, Simon P Castillo, Shiva Vonk, et al.
The Lancet. Digital Health|December 11, 2025
Label-efficient computational tumour infiltrating lymphocyte assessment in breast cancer (ECTIL): multicentre validation in 2340 patients with breast cancerYoni Schirris, Rosie Voorthuis, Mark Opdam, et al.
Nature|December 5, 2024
The oestrous cycle stage affects mammary tumour sensitivity to chemotherapyLaura Bornes, Lennart J van Winden, Veerle C M Geurts, et al.
Cancer Cell|June 13, 2023
Taxanes trigger cancer cell killing in vivo by inducing non-canonical T cell cytotoxicityClaire Vennin, Chiara M Cattaneo, Leontien Bosch, et al.
Cell Reports. Medicine|July 3, 2025
Epigenetic profiling identifies markers of endocrine resistance and therapeutic options for metastatic castration-resistant prostate cancerTesa M Severson, Emma Minnee, Yanyun Zhu, et al.
Nature Communications|June 12, 2020
A cancer drug atlas enables synergistic targeting of independent drug vulnerabilitiesRavi S Narayan, Piet Molenaar, Jian Teng, et al.
Pageof 1